A Phase II study of oral idarubicin as a
✍
Hans-Peter Schmid; Rudolf Maibach; Juerg Bernhard; Franz Hering; Silvia Hanselma
📂
Article
📅
1997
🏛
John Wiley and Sons
🌐
English
⚖ 108 KB
👁 2 views
## Background: Treatment of hormone-refractory prostate carcinoma with chemotherapy is purely palliative, and reported response rates have been low. at the time this study was conducted, there was an urgent need for a trial using potentially efficacious drugs, with quality of life (ql), and serial